Dental products company Envista, which includes the brands Nobel Biocare, Ormco, DEXIS, and Kerr, announced key leadership appointments.
Eric Hammes, who has more than 25 years of operational and financial leadership, was appointed as chief financial officer, effective August 8. Hammes succeeds Stephen Keller, who has served as interim principal financial officer since September 2023. Keller will return to his previous role leading investor relations.
Most recently, Stefan Nilsson, the CEO of European dental service organization Colosseum Dental Group, was appointed as the president of Nobel Biocare. His position was effective July 15.
Finally, Veronica Acurio was appointed president of Ormco, effective August 2. Prior to this position, Acurio worked at 3M's medical device spinoff Solventum.
.DpIowD0Qsf.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.DpIowD0Qsf.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
